HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia.

AbstractBACKGROUND:
Children with cancer frequently have associated cachexia and malnutrition. Failure to thrive affects nearly 40% of oncology patients with advanced or progressive disease. Malnutrition can erode quality of life and adversely impact disease prognosis. Appetite stimulation and increased food intake is 1 approach to combat cancer-related cachexia.
MATERIALS AND METHODS:
Cyproheptadine hydrochloride (CH), an appetite stimulant, was administered to children with cancer-associated cachexia to prevent further weight loss. All participants started CH and were evaluated for response after 4 weeks. Efficacy of megestrol acetate (MA) was evaluated in patients who did not respond to CH. Medical evaluation, weight measurements, prealbumin, and serum leptin levels were preformed at follow-up visits.
RESULTS:
Seventy patients were enrolled. Of the 66 evaluable patients, 50 demonstrated a response to CH (average weight gain 2.6 kg and mean weight-for-age z-score change of 0.35, P=0.001). Seven of the 16 nonresponders received MA. Six patients completed 4 weeks of MA, 5 responded (average weight gain of 2.5 kg). The most commonly reported side effect of CH was drowsiness. One patient on MA developed low cortisol levels and hyperlipidemia.
CONCLUSIONS:
This study demonstrates that CH is a safe and effective way to promote weight gain in children with cancer/treatment-related cachexia.
AuthorsMarisa Couluris, Jennifer L R Mayer, David R Freyer, Eric Sandler, Ping Xu, Jeffrey P Krischer
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 30 Issue 11 Pg. 791-7 (Nov 2008) ISSN: 1536-3678 [Electronic] United States
PMID18989154 (Publication Type: Clinical Trial, Phase II, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Appetite Stimulants
  • Gastrointestinal Agents
  • Cyproheptadine
  • Megestrol Acetate
Topics
  • Adolescent
  • Adult
  • Appetite Stimulants (therapeutic use)
  • Cachexia (drug therapy, etiology)
  • Child
  • Child, Preschool
  • Cyproheptadine (therapeutic use)
  • Female
  • Gastrointestinal Agents (therapeutic use)
  • Humans
  • Male
  • Megestrol Acetate (therapeutic use)
  • Neoplasm Recurrence, Local (diagnosis, drug therapy)
  • Neoplasms (complications, pathology)
  • Prognosis
  • Quality of Life
  • Weight Gain (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: